# OSI-906 and Irinotecan in Patients With Advanced Cancer

> **NCT01016860** · PHASE1 · TERMINATED · sponsor: **University of Colorado, Denver** · enrollment: 16 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** OSI-906
- **DRUG:** irinotecan

## Key facts

- **NCT ID:** NCT01016860
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-12
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** This study was discontinued due to a shown lack of efficacy in the investigational agent
- **Last updated:** 2013-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01016860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01016860, "OSI-906 and Irinotecan in Patients With Advanced Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01016860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*